The second person ever has received a transplant with a genetically modified pig kidney.

The small trial will help to establish whether kidneys from genetically modified pigs can be transplanted into people safely and effectively.

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

The surgery comes at a turning point in the quest to tell if animal-to-human transplants could help ease the shortage of ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

It was the fourth pig kidney transplant in the United States, and the first of three that will be done at Mass General as ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

A team at Massachusetts General Hospital led by Harvard Medical School physician-scientists has for the second time ...

The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...

FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...